Articles

Open access, open innovation

What did open-access once mean in scientific literature, what does it mean now and how does it all play into innovation and the future of science?
Written byPeter Kissinger
| 3 min read

You are now reading an open-access publication. Decades ago, we went to a library and used a card catalog and bound indices such as Chemical Abstracts to identify scholarly works. We could then pull volumes off the shelves and gain enlightenment at a study carrel desk. Some of you will remember those. Later, we could even copy articles of special interest, or order them from a library assistant. Students at the time held printed material in high regard. We wanted to be able to contribute, and a first accepted paper was a welcomed transition to a very special club

While access was open via top-tier technical libraries, access for most citizens of this world was very restricted. The restriction reflected cost. The cost of access reflected the cost of production and only places in academia, government and commercial R&D could afford it.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.